Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)

Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7) Publisher

Rahmah L^{1, 2} ; Abarikwu SO^{3, 4} ; Arero AG^{5, 6} ; Essouma M^{25, 26} ; Jibril AT^{7, 8, 9} ; Fal A^{10, 11, 12} ; Flisiak R¹³ ; Makuku R^{1, 14} ; Marquez L^{15, 16} ; Mohamed K^{1, 17} ; Ndow L^{18, 19} ; Zarebskamichaluk D²⁰ ; Rezaei N^{21, 22, 23} ; Rzymski P^{12, 24}

Show Affiliations

1. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2. Universal Scientific Education and Research Network (USERN), Jakarta, Indonesia
3. Department of Biochemistry, University of Port Harcourt, Choba, Nigeria
4. Universal Scientific Education and Research Network (USERN), Choba, Nigeria
5. Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
6. Universal Scientific Education and Research Network (USERN), Addis Ababa, Ethiopia
7. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
8. Nutritional and Health Team (NHT), Universal Scientific Education and Research Network (USERN), Tehran, Iran
9. Universal Scientific Education and Research Network (USERN), Accra, Ghana
10. Department of Population Health, Division of Public Health, Wroclaw Medical University, Wroclaw, Poland
11. Collegium Medicum, Warsaw Faculty of Medicine, Cardinal Stefan Wyszynski University, Warsaw, Poland
12. Integrated Science Association (ISA), Universal Scientific Education and Research Network (USERN), Poznan, Poland
13. Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland
14. Universal Scientific Education and Research Network (USERN), Harare, Zimbabwe
15. College of Social Sciences and Philosophy, University of the Philippines Diliman, Quezon City, Philippines
16. Education and Research Network (USERN), Universal Scientific, Quezon City, Philippines
17. Universal Scientific Education and Research Network (USERN), Manama, Bahrain
18. National Health Laboratory Service, Kotu, Gambia
19. Universal Scientific Education and Research Network (USERN), Banjul, Gambia
20. Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland
21. Research Center for Immunodeficiencies, Childrenâ€™s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
22. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
23. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
24. Department of Environmental Medicine, Poznan University of Medical Sciences, Poznan, Poland
25. Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon
26. Universal Scientific Education and Research Network, Yaounde, Cameroon

Source: Pharmacological Reports Published:2022

Abstract

The original version of this article unfortunately did not list Mickael Essouma as a co-author who has been involved in the drafting and approving of the manuscript. A correct list of authors is as follows: Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, Mickael Essouma, Aliyu Tijani Jibril, Andrzej Fal, Robert Flisiak, Rangarirai Makuku, Leander Marquez, Kawthar Mohamed, Lamin Ndow, Dorota Zarebska-Michaluk, Nima Rezaei & Piotr Rzymski. © The Author(s) 2022.

Style	Citing Format
MLA	Rahmah L, et al.. "Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)." Pharmacological Reports, vol. 74, no. 6, 2022, pp. 1326-1327.
APA	Rahmah L, Abarikwu SO, Arero AG, Essouma M, Jibril AT, Fal A, Flisiak R, Makuku R, Marquez L, Mohamed K, Ndow L, Zarebskamichaluk D, Rezaei N, Rzymski P (2022). Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7). Pharmacological Reports, 74(6), 1326-1327.
Chicago	Rahmah L, Abarikwu SO, Arero AG, Essouma M, Jibril AT, Fal A, Flisiak R, et al.. "Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)." Pharmacological Reports 74, no. 6 (2022): 1326-1327.
Harvard	Rahmah L et al. (2022) 'Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)', Pharmacological Reports, 74(6), pp. 1326-1327.
Vancouver	Rahmah L, Abarikwu SO, Arero AG, Essouma M, Jibril AT, Fal A, et al.. Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7). Pharmacological Reports. 2022;74(6):1326-1327.
BibTex	@article{ author = {Rahmah L and Abarikwu SO and Arero AG and Essouma M and Jibril AT and Fal A and Flisiak R and Makuku R and Marquez L and Mohamed K and Ndow L and Zarebskamichaluk D and Rezaei N and Rzymski P}, title = {Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)}, journal = {Pharmacological Reports}, volume = {74}, number = {6}, pages = {1326-1327}, year = {2022} }
RIS	TY - JOUR AU - Rahmah L AU - Abarikwu SO AU - Arero AG AU - Essouma M AU - Jibril AT AU - Fal A AU - Flisiak R AU - Makuku R AU - Marquez L AU - Mohamed K AU - Ndow L AU - Zarebskamichaluk D AU - Rezaei N AU - Rzymski P TI - Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7) JO - Pharmacological Reports VL - 74 IS - 6 SP - 1326 EP - 1327 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract